Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 26, 2024 • 2:30 AM ET

Date/Time Source News Release
11/19/2024 09:00 AM EST GlobeNewswire GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
11/12/2024 04:00 PM EST GlobeNewswire GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
11/05/2024 09:00 AM EST GlobeNewswire GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
10/02/2024 09:00 AM EDT GlobeNewswire GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
09/24/2024 07:00 AM EDT GlobeNewswire Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
09/03/2024 09:00 AM EDT GlobeNewswire GeoVax to Participate in Upcoming Investor Conferences in September
08/28/2024 08:59 PM EDT GlobeNewswire GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
08/21/2024 09:00 AM EDT GlobeNewswire Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab's CEO
08/20/2024 07:45 AM EDT GlobeNewswire GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
08/20/2024 07:00 AM EDT GlobeNewswire Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
Page

Additional News

As of November 26, 2024 • 2:30 AM ET

Date/Time Source News Release
Page